Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 11Neoplasms 4Adenocarcinoma of Lung 4Brain Neoplasms 3Adenocarcinoma, Bronchiolo-Alveolar 3Neoplasm Metastasis 2NSCLC 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Respiratory Tract Diseases 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1Head and Neck Neoplasms 1EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1Carcinoma 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

Oxaliplatin 10Fluorouracil 7Leucovorin 6Gemcitabine 6Docetaxel 6Capecitabine 6Paclitaxel 5Cisplatin 5zolbetuximab 4Ramucirumab 3Pemetrexed 3Drug Therapy 3Carboplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3regorafenib 2pembrolizumab 2Vinorelbine 2Surgical Procedures, Operative 2Radiotherapy 2Nivolumab 2Neoadjuvant Therapy 2Cyclophosphamide 2Chemoradiotherapy 2Bevacizumab 2Afatinib 2vandetanib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma × Gefitinib × Clear all
NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

National Cancer Center, Korea

Phase 3 Completed
315 enrolled
Thoracic

Adenocarcinoma, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡